Relevant Reports All ReportsTreatment and Clinical GuidelinesSubstance Use and Overdose DataBackground KnowledgePublic SafetyMiscellaneous Gabapentin Background Report Methamphetamine Background Report 2018 Regional Pennsylvania Stimulant Reports 2018 Pennsylvania Stimulant Report ACOPC: 2019 Summer Conference Presentations Medication-Assisted Treatment of Opioid Use Disorder Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care- Outcomes During and After Intervention Methadone Deaths- Risk Factors in Pain and Addicted Populations Buprenorphine Maintenance versus Placebo or Methadone: Maintenance for Opioid Dependence (Review) Self-treatment: Illicit Buprenorphine Use by Opioid-Dependent Treatment Seekers Tapering Toolkit Provider Resource TIP 63 Medications for Opioid Use Disorder: Executive Summary Federal Regulation of Methadone Treatment Heroin-Dependent Inmates’ Experiences with Buprenorphine or Methadone Maintenance Release from Prison — A High Risk of Death for Former Inmates Jail Management of Arrestees/Inmates Enrolled in Community Methadone Maintenance Programs Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers & Intentions Medication Assisted Treatment Research with Criminal Justice Populations: Challenges of Implementation Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System A National Case-Control Study of Risk Factors Among Prisoners in England and Wales Buprenorphine-Naloxone Maintenance Following Release from Jail Buprenorphine and Methadone Maintenance in Jail and Post-Release: A Randomized Clinical Trial Does Exposure to Opioid Substitution Treatment in Prison Reduce the Risk of Death after Release? A National Prospective Observational Study in England The Effect of a Jail Methadone Maintenance Therapy (MMT) Program on Inmate Recidivism Meta-Analysis of Drug-Related Deaths Soon After Release from Prison A Typology of Male Prisoners Making Near-Lethal Suicide Attempts State of the Art and Science: Why It’s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy Safety of the Newer Class of Opioid Antagonists in Pregnancy Buprenorphine Compared with Methadone to Treat Pregnant Women with Opioid Use Disorder-A Systematic Review and Meta-analysis of Safety in the Mother, Fetus, and Child Decision Science can Help Policymakers to Identify and Evaluate Policies to Treat Opioid Use Disorder Among Pregnant Women Maintenance Agonist Treatments for Opiate-Dependent Pregnant Women Infants of Opioid-Dependent Mothers-Neurodevelopment at Six Months Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome Treatment of Opioid-Dependent Pregnant Women-Clinical and Research Issues Clinical Care for Opioid-Using Pregnant and Postpartum Women A Review of Recent Findings on Substance Abuse Treatment for Pregnant Women Using Behavioral Economic Theory to Increase Use of Effective Contraceptives among Opioid-Maintained Women at Risk of Unintended Pregnancy Management of Women Treated with Buprenorphine During Pregnancy State and Local Policy Levers for Increasing Treatment and Recovery Capacity to Address the Opioid Epidemic Fentanyl Drug Facts Pennsylvania Youth State Survey Report 2017 DEA: Legal cases against doctors The Underestimated Cost of the Opioid Crisis The Economic Cost of the Opioid Epidemic in Pennsylvania SAMHSA Opioid Overdose Prevention Toolkit The National Practice Guidelines for the Use of Medications in the Treatment of Addiction Involving Opioid Use Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health Access to Substance Use Disorder Treatment in Medicaid Evidence Based Strategies for Preventing Opioid Overdose: What’s Working in the United States Neonatal and Maternal Hospitalizations related to substance misuse Pennsylvania Drug and Alcohol Annual Plan and Report 2015-2016 Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas Drug Overdose Deaths in the United States, 1999-2006 CDC: 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes CDC: 2017 Annual Surveillance Report of Drug-Related Risks and Outcomes International Narcotics Control Strategy Report Public Opinion of Prescription Drug Abuse and Disposal The Health and Social Effects of Nonmedical Cannabis Use Neuroscience of Psychoactive Substance Use and Dependence Drugs, Brains, and Behavior: The Science of Addiction Drug-Related Overdose Deaths in Pennsylvania, 2018: A Joint Report with the Drug Enforcement Administration and University of Pittsburgh School of Pharmacy ACOPC: 2017 Summer Conference Presentations ACOPC: 2018 Summer Conference Presentations DEA: Carfentanil in Pennsylvania DEA: Cocaine/Fentanyl Combination in Pennsylvania DEA: Drug Presence in Pennsylvania 1999-2016 Prehospital Opioid Safety DEA: 2017 National Drug Threat Assessment DEA: Emerging Threat Report Naloxone Information Sheet DEA: Colombian Cocaine Production Expansion Contributes to Rise in Supply in the United States DEA: 2015 Heroin Signature Program Report DEA: Analysis of Overdose Deaths in Pennsylvania 2016 Performance Audit Reports: Opioid Treatment Audits NIH Efforts to Reduce the Opioid Epidemic DEA: Fentanyl Guide for First Responders Developing a Stigma Reduction Initiative NFLIS: 2016 Mid Year Report DEA: 2016 National Drug Threat Assessment ED Treatment for Opioid Dependence Citizen Science: Naloxone Availability in Allegheny County Pharmacies
Emergency